Latest Breaking News On - David fiellin - Page 7 : comparemela.com

The Hartford Announces Pilot To Train Connecticut Medical Providers On Addiction, Pain Management, and Stigma

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesKelly carterDavid fiellinJeanette tetraultFred mamounRichard blumenthalExchange commissionHartford financial services group incYale school of medicineYale program in addiction medicineNational alliance on mental illnessYale programAddiction medicineYale schoolNational allianceMental illness

The millions of dollars from the opioid settlement must be used to immediately save lives, advocates say Halting fentanyl epidemic should be top priority

The millions of dollars from the opioid settlement must be used to immediately save lives, advocates say Halting fentanyl epidemic should be top priority
courant.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from courant.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesFrog hollowYale new haven hospitalFairfield countyNed lamontCourtney hunterMark mirkoCoutant skinnerDavid fiellinMaria coutant skinnerSpencer platt gettyMark jenkinMark jenkinsEliza fawcettWilliam tong

High-dose buprenorphine in EDs may improve patient outcomes

By Susan Gonzalez July 15, 2021 Share this with FacebookShare this with TwitterShare this with LinkedInShare this with EmailPrint this (© stock.adobe.com) The administration of high-dose buprenorphine therapy in hospital emergency departments (ED) may safely and rapidly diminish withdrawal symptoms and sustain craving suppression in people with opioid use disorder, improving their likelihood of accessing follow-up treatment, according to a study co-authored by Yale’s Gail D’Onofrio. Buprenorphine is a medication approved by the U.S. Food and Drug Administration to treat opioid use disorder. Giving lower doses of the medication is the current standard of care. The study found, however, that giving higher doses of buprenorphine in EDs may provide a longer period of relief to people after they are discharged, which may help them navigate barriers to access to follow-up care before they experience withdrawal symptoms.

United statesDavid fiellinNorad volkowAlberte kentYale gail donofrioYale program in addiction medicineNational institute on drug abuseAlameda health systemYale school of medicineClinical trials networkNational institutes of healthUs department of healthHuman servicesDrug administrationDepartment of emergency medicineInitiative on opioids

Addiction Medicine 101: Prevention & Treatments | Yale Alumni Association

What is addiction and how do we help individuals struggling with substance use? Learn about the science and history of addiction medicine, innovations in the diagnosis, treatment, and prevention of substance use disorder, and what Yale is doing to bring the science of addiction to primary care, emergency departments, hospitals and more. Join Addiction physicians and experts - Drs.

David fiellinGail donofrioJeanette tetraultMelissa weimerYale program in addiction medicineYale alumni health networkYale alumni association shared interest groupsGaild onofrioYale programAddiction medicineYale alumni association shared interestகெயில் டோனோஃப்ரியோஜீனெட் டெட்ரால்ட்மெலிசா வீமர்யேல் ப்ரோக்ர்யாம் இல் மருந்துயேல் முன்னாள் மாணவர்கள் ஆரோக்கியம் வலைப்பின்னல்

Make Harm Reduction Federal Health Policy Now, Say Yale Experts

May 08, 2021 by Julie Parry Since the start of the COVID-19 pandemic over a year ago, alcohol and substance use has surged in the United States, along with overdoses from opioids. To save lives, using practical strategies to reduce the negative effects of substance use, or harm reduction strategies should become federal health policy now, urges experts Kimberly Sue, MD, PhD, and David Fiellin, MD, from the Yale Program in Addiction Medicine. The New England Journal of Medicine, they urge the Biden administration to name, embrace, and implement harm reduction programs to save American lives. In addition to expanding treatment, they argue, there is a need for additional measures to abate the tidal wave of death from overdoses. Additionally, they say funds should be allocated to combat the health inequities and racial injustice for Black Americans who are suffering from a disproportionate rise in deaths from substance use disorders, along with COVID-19.

United statesNew yorkDavid fiellinYale program in addiction medicineCenters for diseaseDepartment of justiceHuman servicesSubstance abuse mental health service administrationOffice of national drug controlNational harm reduction coalitionKimberly sueYale programHarm reductionHealth policyOverdose crisisNew england journal